如何进入英国医药市场的.pptVIP

Pros and cons of single channel distribution Advantages For manufacturer Lower wholesale margin Lower administrative costs Only one drop-off point Lower credit risk Better inventory control Access to real-time data on realised sales Improved communication and co-operation with wholesaler Wholesalers do not need to compete with discounts Recalls are easier No reports of counterfeit entry into either Finnish or Swedish markets Disadvantages One wholesaler carries the sole responsibility for stocking and delivering a product throughout country Antitrust concerns – pharmacies are unable to select suppliers MA between manufacturers can produce big shift in wholesaler market shares Service levels to pharmacies may be less because of a lack of competition for their business from wholesalers. Many other features of UK pharma landscape are changing/poised to change Regional split of UK/devolution of NHS budget to HAs and trusts OFT recommendation to replace PPRS with ‘value-based pricing’ NICE: new STA process/Health Select Committee inquiry/legal challenge Review of value for money of primary care prescribing by NAO Review of wholesale margin by DoH Review of prescription charge/exemptions by Health Select Committee Implementation of new pharmacy contracts Volatility with generic reimbursement DoH proposal to remove branded generics from PPRS Curtailment of ZD list Private equity takeover of Alliance Boots Thoughts on the future Wholesaling will never be the same. Future single agency schemes unlikely in short term. Current UK geographical coverage of even largest wholesalers not perfect…. top 2: 85-95% top 3: 90-95% top 5: 97% (Source: Taylor Nelson Sofres/AT Kearney) …..but there will be more consolidation. PSNC will insist that pharmacies in England Wales collectively retain ￡500 million purchase discounts – DoH forced to adjust dispensing fee, clawback scale or Cat M generic prices? Onus will be on manufacturers introducing direct-to-pharmacy schemes to ensure vi